The Open Infectious Diseases Journal




ISSN: 1874-2793 ― Volume 11, 2019
CASE REPORT

Chronic Granulomatous Disease Revealed by Multiple Cystic and Pseudo-tumoral Liver Lesions: One Case Report



Ibtissam Khattou1, *, Imane Ait Sab1, Noureddine Rada1, Aicha Bourrahouat1, Btissam Zouita2, Dounia Basraoui2, Hicham Jalal2, Mohamed Sbihi1
1 Department of pediatrics CHU Mohammed VI Marrakech, Marrakech, Morocco
2 Department of radiology CHU Mohammed VI Marrakech, Marrakech, Morocco

Abstract

Chronic Granulomatous Disease (CGD) is a rare immunodeficiency disease described as a lack of destruction of bacteria and fungi phagocytes by neutrophils and macrophages, it is related to an abnormality of NADPH oxidase, a free radical producer of oxygen. The most common aspect of CGD at the age of one year, is an infection of the skin or bone by two bacteria called staphylococcus aureus and serratia marcescens. In this article, the authors report a case of CGD revealed by multiple cystic and pseudo-tumoral liver lesions discovered during prolonged fever.

Keywords: Chronique granulomatous disease, Hepatic abscess, Immunodeficiency, Recurrent infections, Lesions, Macrophages.


Article Information


Identifiers and Pagination:

Year: 2018
Volume: 10
First Page: 151
Last Page: 155
Publisher Id: TOIDJ-10-151
DOI: 10.2174/1874279301810010151

Article History:

Received Date: 4/8/2018
Revision Received Date: 3/10/2018
Acceptance Date: 10/10/2018
Electronic publication date: 24/10/2018
Collection year: 2018

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 213
Abstract HTML Views: 280
PDF Downloads: 139
ePub Downloads: 113
Total Views/Downloads: 745

Unique Statistics:

Full-Text HTML Views: 123
Abstract HTML Views: 210
PDF Downloads: 91
ePub Downloads: 72
Total Views/Downloads: 496
Geographical View

© 2018 Khattou et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


* Address correspondence to this author at the Department of pediatrics, CHU Mohammed VI Marrakech, Marrakech, Morocco; Tel: +00212678672677; E-mail: Khattou@live.fr




1. INTRODUCTION

Chronic Granulomatous Disease (CGD) is a rare immunodeficiency disease, secondary to a defect in the oxidative metabolism of phagocytes. The particularity of this article is to report a rare case of immune deficiency, revealed by an unusual radiological aspect. We report a case of CGD that is revealed by multiple cystic and pseudo-tumoral liver lesions.

2. CASE REPORT

The case was 2-year and 2-month-old female child, who had consanguineous parents, and having a history of repeated respiratory infections. She was admitted to our department for prolonged fever with deterioration of the general state, and in whom, the clinical examination found a failure to thrive (weight; 10kg (<-3SD) and height 78cm (<-3SD)), with nodular hepatomegaly at abdominal palpation.

The biological assessment showed hyperleukocytosis at 23310 elements/mm3 predominantly neutrophilic at 16600 elements/mm3. C-reactive protein (CRP) was elevated to 214 mg / l.

Abdominal ultrasound showed hepatic lesion taking the whole left liver measuring 81 * 57mm poorly limited with heterogeneous echo-structure, no flow in Doppler with the existence of another hepatic lesion at segment 4 measuring 22 * 16mm hyperechoic center surrounded by a hypoechoic halo and ill-defined borders.

Thoraco-abdominopelvic CT revealed a locally infiltrated left liver lesion involving the right hepatic artery associated with multifocal cystic lesions at the liver (Figs. 1A, B and 2), right thoracic wall lesion, and left excavated pulmonary lesion. These images indicate secondary locations (Figs. 3 and 4).

Fig. (1)
(A) multi-leaf formation with thick wall, centered by a vessel, pseudo-tumor aspect (B) Infiltrating the hilar bifurcation responsible for portal thrombosis.


Fig. (2)
Multiple Cystic and Liver Tissue lesions.


Fig. (3)
Liquid thoracic wall mass with thick walls.


Fig. (4)
Excavated parenchymal condensation.


The dosage of alpha-fetoprotein was normal. A percutaneous liver biopsy was done but it was inconclusive which led to a surgical biopsy. The histopathological study showed a liver abscess without signs of malignancy and no isolate was identified. The patient was treated with tri-antibiotic therapy (Ceftriaxone + Gentamicin + Metronidazole). The lesion evolved toward the constitution of an abscess in front of the operative wound which was drained and the bacteriological study of the pus isolated Serratia marcescens.

Faced the hepatic abscess and the isolated bacteria, the diagnosis of immunodeficiency was suggested. An HIV serology was performed which was negative, the dosage of immunoglobulin and lymphocyte was normal. The exploration of oxidative burst of PNN (Neutrophil polynuclear) has shown a lack of response from the PNN (Dihydrorhodamine test).

The diagnosis of chronic septic granulomatous disease was retained and the patient was made to experience under anti-microproteinase basically trimethoprim-sulfamethoxazole with a good progress.

3. DISCUSSION

Chronic Granulomatous Disease (CGD) is a rare, primitive immune deficiency of genetic origin; the incidence is estimated to be between 1/200,000 and 1/250,000 births in the United States [1Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79(3): 155-69.[http://dx.doi.org/10.1097/00005792-200005000-00003] [PMID: 10844935] ], it is secondary to a defect in the oxidative metabolism of neutrophils, monocytes, macrophages and eosinophils [2Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79(3): 170-200.[http://dx.doi.org/10.1097/00005792-200005000-00004] [PMID: 10844936] ]. It is revealed by recurrent bacterial and fungal infections and by the development of granulomas with multi-visceral involvement. CGD usually occurs before the age of five, but it can be diagnosed in adulthood [3Liese JG, Jendrossek V, Jansson A, et al. Chronic granulomatous disease in adults. Lancet 1996; 347(8996): 220-3.[http://dx.doi.org/10.1016/S0140-6736(96)90403-1] [PMID: 8551880] ]. The favorite sites are lungs (80%), skin (60-70%), lymph nodes (75%), liver and digestive tract (32%) [4van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: The European experience. PLoS One 2009; 4(4): e5234.[http://dx.doi.org/10.1371/journal.pone.0005234] [PMID: 19381301] ].Chronic inflammatory signs, particularly hepatic granulomatous infiltration responsible for hepatomegaly reported in 80-100% of cases [5Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114(2): 462-8.[http://dx.doi.org/10.1542/peds.114.2.462] [PMID: 15286231] ], are among the cardinal signs of the disease. The diagnosis is based on the exploration of granulocyte bactericide mainly by an easy reduction test; the Nitroblue Tetrazolium (NBT) which remains the screening test of choice for this pathology.It is based on the activation of NADPH granulocyte oxidase by soluble agents, the Phorbol Myristate Acetate (PMA) in the presence of NBT. But the current trend is to develop the measurement of the fluorescence of dihydrorhodamine (DHR) in the presence of toxic derivatives of oxygen (ROS) [6Stasia MJ, Cathebras P, Lutz MF, Durieu I. Chronic-granulomatous disease. Rev Med Interne 2009; 30(3): 221-32.[http://dx.doi.org/10.1016/j.revmed.2008.05.023] [PMID: 18640747] , 7Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363(27): 2600-10.[http://dx.doi.org/10.1056/NEJMoa1007097] [PMID: 21190454] ].The genetic study allows determining the CGD original mutation which will guide any possible familial study, but also it makes it possible proposing genetic counseling to the parents, as the possibility of an antenatal diagnosis during future pregnancy [6Stasia MJ, Cathebras P, Lutz MF, Durieu I. Chronic-granulomatous disease. Rev Med Interne 2009; 30(3): 221-32.[http://dx.doi.org/10.1016/j.revmed.2008.05.023] [PMID: 18640747] ].

Children with CGD should receive anti-aspergilla and antibacterial chemoprophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX), which is the most commonly used antibiotic because it has a good spectrum of activity on microorganisms faced in the CGD.TMP-SMX is lipophilic (therefore concentrated in the cell) and well tolerated, since it does not affect the intestinal flora [6Stasia MJ, Cathebras P, Lutz MF, Durieu I. Chronic-granulomatous disease. Rev Med Interne 2009; 30(3): 221-32.[http://dx.doi.org/10.1016/j.revmed.2008.05.023] [PMID: 18640747] ]. Thanks to the natural evolution (reduction of infectious episodes with age) and therapeutic progress, especially of anti-infectious prophylaxis, patients diagnosed in childhood reach adulthood and can lead normal personal and professional life [8Liese J, Kloos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000; 137(5): 687-93.[http://dx.doi.org/10.1067/mpd.2000.109112] [PMID: 11060536] ].

Bone marrow allograft, the only curative treatment for CGD, is only possible when there is a compatible HLA donor. Gene therapy using a vector (retrovirus or adenovirus) is a potential future treatment [9Thrasher A, Chetty M, Casimir C, Segal AW. Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer. Blood 1992; 80(5): 1125-9.[PMID: 1325210] ] as had been shown in the treatment of severe combined immunodeficiency [10Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: Are we there yet? J Clin Invest 2007; 117(6): 1456-65.[http://dx.doi.org/10.1172/JCI30953] [PMID: 17549248] ].

CONCLUSION

The CGD is a rare primary immunodeficiency, the evolution of which under antibioprophylaxis is generally favorable; it should be suggested before any deep abscess in child and before any infection with unusual germs such as Burkholderia cepacia, Serratia marcescens, aspergillus and Nocardia.

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Not applicable.

HUMAN AND ANIMAL RIGHTS

No animals/humans were used for studies that are the basis of this report.

CONSENT FOR PUBLICATION

A written informed consent was obtained from the parents.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

ACKNOWLEDGEMENTS

Declared none.

REFERENCES

[1] Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79(3): 155-69.[http://dx.doi.org/10.1097/00005792-200005000-00003] [PMID: 10844935]
[2] Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79(3): 170-200.[http://dx.doi.org/10.1097/00005792-200005000-00004] [PMID: 10844936]
[3] Liese JG, Jendrossek V, Jansson A, et al. Chronic granulomatous disease in adults. Lancet 1996; 347(8996): 220-3.[http://dx.doi.org/10.1016/S0140-6736(96)90403-1] [PMID: 8551880]
[4] van den Berg JM, van Koppen E, Ahlin A, et al. Chronic granulomatous disease: The European experience. PLoS One 2009; 4(4): e5234.[http://dx.doi.org/10.1371/journal.pone.0005234] [PMID: 19381301]
[5] Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004; 114(2): 462-8.[http://dx.doi.org/10.1542/peds.114.2.462] [PMID: 15286231]
[6] Stasia MJ, Cathebras P, Lutz MF, Durieu I. Chronic-granulomatous disease. Rev Med Interne 2009; 30(3): 221-32.[http://dx.doi.org/10.1016/j.revmed.2008.05.023] [PMID: 18640747]
[7] Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010; 363(27): 2600-10.[http://dx.doi.org/10.1056/NEJMoa1007097] [PMID: 21190454]
[8] Liese J, Kloos S, Jendrossek V, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000; 137(5): 687-93.[http://dx.doi.org/10.1067/mpd.2000.109112] [PMID: 11060536]
[9] Thrasher A, Chetty M, Casimir C, Segal AW. Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer. Blood 1992; 80(5): 1125-9.[PMID: 1325210]
[10] Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: Are we there yet? J Clin Invest 2007; 117(6): 1456-65.[http://dx.doi.org/10.1172/JCI30953] [PMID: 17549248]

Endorsements



"Open access will revolutionize 21st century knowledge work and accelerate the diffusion of ideas and evidence that support just in time learning and the evolution of thinking in a number of disciplines."


Daniel Pesut
(Indiana University School of Nursing, USA)

"It is important that students and researchers from all over the world can have easy access to relevant, high-standard and timely scientific information. This is exactly what Open Access Journals provide and this is the reason why I support this endeavor."


Jacques Descotes
(Centre Antipoison-Centre de Pharmacovigilance, France)

"Publishing research articles is the key for future scientific progress. Open Access publishing is therefore of utmost importance for wider dissemination of information, and will help serving the best interest of the scientific community."


Patrice Talaga
(UCB S.A., Belgium)

"Open access journals are a novel concept in the medical literature. They offer accessible information to a wide variety of individuals, including physicians, medical students, clinical investigators, and the general public. They are an outstanding source of medical and scientific information."


Jeffrey M. Weinberg
(St. Luke's-Roosevelt Hospital Center, USA)

"Open access journals are extremely useful for graduate students, investigators and all other interested persons to read important scientific articles and subscribe scientific journals. Indeed, the research articles span a wide range of area and of high quality. This is specially a must for researchers belonging to institutions with limited library facility and funding to subscribe scientific journals."


Debomoy K. Lahiri
(Indiana University School of Medicine, USA)

"Open access journals represent a major break-through in publishing. They provide easy access to the latest research on a wide variety of issues. Relevant and timely articles are made available in a fraction of the time taken by more conventional publishers. Articles are of uniformly high quality and written by the world's leading authorities."


Robert Looney
(Naval Postgraduate School, USA)

"Open access journals have transformed the way scientific data is published and disseminated: particularly, whilst ensuring a high quality standard and transparency in the editorial process, they have increased the access to the scientific literature by those researchers that have limited library support or that are working on small budgets."


Richard Reithinger
(Westat, USA)

"Not only do open access journals greatly improve the access to high quality information for scientists in the developing world, it also provides extra exposure for our papers."


J. Ferwerda
(University of Oxford, UK)

"Open Access 'Chemistry' Journals allow the dissemination of knowledge at your finger tips without paying for the scientific content."


Sean L. Kitson
(Almac Sciences, Northern Ireland)

"In principle, all scientific journals should have open access, as should be science itself. Open access journals are very helpful for students, researchers and the general public including people from institutions which do not have library or cannot afford to subscribe scientific journals. The articles are high standard and cover a wide area."


Hubert Wolterbeek
(Delft University of Technology, The Netherlands)

"The widest possible diffusion of information is critical for the advancement of science. In this perspective, open access journals are instrumental in fostering researches and achievements."


Alessandro Laviano
(Sapienza - University of Rome, Italy)

"Open access journals are very useful for all scientists as they can have quick information in the different fields of science."


Philippe Hernigou
(Paris University, France)

"There are many scientists who can not afford the rather expensive subscriptions to scientific journals. Open access journals offer a good alternative for free access to good quality scientific information."


Fidel Toldrá
(Instituto de Agroquimica y Tecnologia de Alimentos, Spain)

"Open access journals have become a fundamental tool for students, researchers, patients and the general public. Many people from institutions which do not have library or cannot afford to subscribe scientific journals benefit of them on a daily basis. The articles are among the best and cover most scientific areas."


M. Bendandi
(University Clinic of Navarre, Spain)

"These journals provide researchers with a platform for rapid, open access scientific communication. The articles are of high quality and broad scope."


Peter Chiba
(University of Vienna, Austria)

"Open access journals are probably one of the most important contributions to promote and diffuse science worldwide."


Jaime Sampaio
(University of Trás-os-Montes e Alto Douro, Portugal)

"Open access journals make up a new and rather revolutionary way to scientific publication. This option opens several quite interesting possibilities to disseminate openly and freely new knowledge and even to facilitate interpersonal communication among scientists."


Eduardo A. Castro
(INIFTA, Argentina)

"Open access journals are freely available online throughout the world, for you to read, download, copy, distribute, and use. The articles published in the open access journals are high quality and cover a wide range of fields."


Kenji Hashimoto
(Chiba University, Japan)

"Open Access journals offer an innovative and efficient way of publication for academics and professionals in a wide range of disciplines. The papers published are of high quality after rigorous peer review and they are Indexed in: major international databases. I read Open Access journals to keep abreast of the recent development in my field of study."


Daniel Shek
(Chinese University of Hong Kong, Hong Kong)

"It is a modern trend for publishers to establish open access journals. Researchers, faculty members, and students will be greatly benefited by the new journals of Bentham Science Publishers Ltd. in this category."


Jih Ru Hwu
(National Central University, Taiwan)


Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open